Literature DB >> 16775359

Active viremia in rotavirus-infected mice.

Sarah E Blutt1, Martijn Fenaux, Kelly L Warfield, Harry B Greenberg, Margaret E Conner.   

Abstract

Rotavirus circulates extraintestinally in animals used as models for rotavirus infection and in children. Rotavirus infection in mice was used to define host or viral factors that affect rotavirus viremia. Antigenemia was observed with homologous and heterologous rotaviruses, and neither age nor mouse strain genetics altered the occurrence of rotavirus antigenemia or viremia. Rotavirus RNA and infectious virus were present in sera and associated with the plasma fraction of blood in all infected mice. These findings indicate that antigenemia/viremia occurs routinely in rotavirus infections and imply that infectious rotavirus has access to any extraintestinal cell within contact of blood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775359      PMCID: PMC1488936          DOI: 10.1128/JVI.00329-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Histologic distribution of fatal rotaviral infection: an immunohistochemical and reverse transcriptase in situ polymerase chain reaction analysis.

Authors:  C Morrison; T Gilson; G J Nuovo
Journal:  Hum Pathol       Date:  2001-02       Impact factor: 3.466

2.  Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs).

Authors:  Sarah E Blutt; Kelly L Warfield; Christine M O'Neal; Mary K Estes; Margaret E Conner
Journal:  Vaccine       Date:  2005-09-09       Impact factor: 3.641

3.  Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus.

Authors:  M S Azevedo; L Yuan; K-I Jeong; A Gonzalez; T V Nguyen; S Pouly; M Gochnauer; W Zhang; A Azevedo; L J Saif
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Rotavirus gastroenteritis and central nervous system (CNS) infection: characterization of the VP7 and VP4 genes of rotavirus strains isolated from paired fecal and cerebrospinal fluid samples from a child with CNS disease.

Authors:  M Iturriza-Gómara; I A Auchterlonie; W Zaw; P Molyneaux; U Desselberger; J Gray
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

Authors:  N Feng; J W Burns; L Bracy; H B Greenberg
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Viremia and extraintestinal infections in infants with rotavirus diarrhea.

Authors:  Ning Li; Zhi-yuan Wang
Journal:  Di Yi Jun Yi Da Xue Xue Bao       Date:  2003-07

7.  A comparison of the effects of oral inoculation with Rotashield and pentavalent reassortant rotavirus vaccine (WC3-PV) on suckling CB17scid mice.

Authors:  Haiping Qiao; H Fred Clark; Matthew DiVietro; Marie Riepenhoff-Talty
Journal:  J Gen Virol       Date:  2004-08       Impact factor: 3.891

8.  Histologic distribution of fatal rotaviral pneumonitis: an immunohistochemical and RT in situ PCR analysis.

Authors:  Gerard J Nuovo; Geraldine Owor; Thomas Andrew; Cynthia Magro
Journal:  Diagn Mol Pathol       Date:  2002-09

9.  The pathology of rotavirus-associated deaths, using new molecular diagnostics.

Authors:  Maureen Lynch; Wun-Ju Shieh; Kathleen Tatti; Jon R Gentsch; Tara Ferebee-Harris; Baoming Jiang; Jeannette Guarner; Joesph S Bresee; Margaret Greenwald; Steve Cullen; H D Davies; Cynthia Trevenen; Sherif R Zaki; Roger I Glass
Journal:  Clin Infect Dis       Date:  2003-10-23       Impact factor: 9.079

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  20 in total

1.  Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses.

Authors:  Shannon M Mumphrey; Harish Changotra; Tara N Moore; Ellen R Heimann-Nichols; Christiane E Wobus; Michael J Reilly; Mana Moghadamfalahi; Deepti Shukla; Stephanie M Karst
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Expression of rotavirus NSP4 alters the actin network organization through the actin remodeling protein cofilin.

Authors:  Zuzana Berkova; Sue E Crawford; Sarah E Blutt; Andrew P Morris; Mary K Estes
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Immune mediators of rotavirus antigenemia clearance in mice.

Authors:  Glendie Marcelin; Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

4.  Human rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo.

Authors:  Carlos F Narváez; Ningguo Feng; Camilo Vásquez; Adrish Sen; Juana Angel; Harry B Greenberg; Manuel A Franco
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

5.  Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts.

Authors:  Iyadh Douagi; Gerald M McInerney; Asa S Hidmark; Vassoula Miriallis; Kari Johansen; Lennart Svensson; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

6.  Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia.

Authors:  Paula M Hertel; Sue E Crawford; Milton J Finegold; Mary K Estes
Journal:  Virology       Date:  2011-07-13       Impact factor: 3.616

7.  Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles.

Authors:  Paula M Hertel; Sue E Crawford; Brooke C Bessard; Mary K Estes
Journal:  Vaccine       Date:  2013-07-22       Impact factor: 3.641

8.  Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model.

Authors:  Ana M González; Marli S P Azevedo; Kwonil Jung; Anastasia Vlasova; Wei Zhang; Linda J Saif
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

9.  TLR3, TRIF, and caspase 8 determine double-stranded RNA-induced epithelial cell death and survival in vivo.

Authors:  Christopher S McAllister; Omar Lakhdari; Guillaume Pineton de Chambrun; Mélanie G Gareau; Alexis Broquet; Gin Hyug Lee; Steven Shenouda; Lars Eckmann; Martin F Kagnoff
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

10.  Rotavirus Degrades Multiple Interferon (IFN) Type Receptors To Inhibit IFN Signaling and Protects against Mortality from Endotoxin in Suckling Mice.

Authors:  Adrish Sen; Ayushi Sharma; Harry B Greenberg
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.